Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions
Year: 2004
Type: article
Abstract: Diabetes in humans accelerates cardiovascular disease caused by atherosclerosis. The relative contributions of hyperglycemia and dyslipidemia to atherosclerosis in patients with diabetes are not clear, largely because there is a lack of suitable animal models. We therefore have developed a transgenic mouse model that closely mimics atherosclerosis in humans with type 1 diabetes by breeding low-density lipoprotein receptor-deficient mice with transgenic mice in which type 1 diabetes can be induced at will. These mice express a viral protein under control of the insulin promoter and, when infected by the virus, develop an autoimmune attack on the insulin-producing beta cells and subsequently develop type 1 diabetes. When these mice are fed a cholesterol-free diet, diabetes, in the absence of associated lipid abnormalities, causes both accelerated lesion initiation and increased arterial macrophage accumulation. When diabetic mice are fed cholesterol-rich diets, on the other hand, they develop severe hypertriglyceridemia and advanced lesions, characterized by extensive intralesional hemorrhage. This progression to advanced lesions is largely dependent on diabetes-induced dyslipidemia, because hyperlipidemic diabetic and nondiabetic mice with similar plasma cholesterol levels show a similar extent of atherosclerosis. Thus, diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.
DOI: 10.1172/jci17867
Institutions: University of Washington, La Jolla Institute for Immunology
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: G1615432403, G1948980911, G2862734185, LONG-CHAIN ACYL-COA SYNTHETASES IN VASCULAR CELLS, Aging Disease--Prion/Transgenic/Immunologic Studies, PATHOGENESIS AND TREATMENT OF AUTOIMMUNE DIABETES, G6456589418, Cell Signaling: Macrovascular Complications of Diabetes, DNA Vaccination & Regulatory Cells in Type I Diabetes, Pathobiology of Macrovascular Disease in Diabetes, Multidisciplinary Training in Critical Care Outcomes Research, Nutrition Obesity Research Center, Diabetes Research Center
OpenAlex ID: W2082913643
